Silk Embolic Material for Catheter-Directed Endovascular Drug Delivery

Jingjie Hu, Hassan Albadawi, Zefu Zhang, Marcela A. Salomao, Seyda Gunduz, Suliman Rehman, Luciana D'Amone, Joseph L. Mayer, Fiorenzo Omenetto, Rahmi Oklu

Research output: Contribution to journalArticlepeer-review

Abstract

Embolization is a catheter-based minimally invasive procedure that deliberately occludes diseased blood vessels for treatment purposes. A novel silk-based embolic material (SEM) that is developed and optimized to provide tandem integration of both embolization and the delivery of therapeutics is reported. Natural silk is processed into fibroin proteins of varying lengths and is combined with charged nanoclay particles to allow visibility and injectability using clinical catheters as small as 600 μm in diameter at lengths >100 cm. SEMs loaded with fluorochrome labeled bovine albumin and Nivolumab, which is among the most used immunotherapy drugs worldwide, demonstrate a sustained release profile in vitro over 28 days. In a porcine renal survival model, SEMs with labeled albumin and Nivolumab successfully embolize porcine arteries without recanalization and lead to the delivery of both albumin and Nivolumab into the interstitial space of the renal cortex. Mechanistically, it is shown that tissue delivery is most optimal when the internal elastic membrane of the embolized artery is disrupted. SEM is a potential next-generation multifunctional embolic agent that can achieve embolization and deliver a wide range of therapeutics to treat vascular diseases including tumors.

Original languageEnglish (US)
JournalAdvanced Materials
DOIs
StateAccepted/In press - 2021

Keywords

  • embolization
  • immunotherapy
  • nanoclay
  • silk
  • vascular interventions

ASJC Scopus subject areas

  • Materials Science(all)
  • Mechanics of Materials
  • Mechanical Engineering

Fingerprint

Dive into the research topics of 'Silk Embolic Material for Catheter-Directed Endovascular Drug Delivery'. Together they form a unique fingerprint.

Cite this